poisar

Stock

Sonoma Pharmaceuticals, Inc. SNOA

$1.35-2.53%

Overview

SNOA market data

Price History

SNOA price chart · 3M
O
1.38
H
1.40
L
1.33
C
1.35
Vol
1,063.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.38
Previous Close
$1.39
Day High
$1.40
Day Low
$1.33
52 Week High
$1.44
52 Week Low
$1.01
7 Day Return
+0.75%
30 Day Return
+17.39%
90 Day Return
+16.38%
1 Year Return
+25.00%
Daily Notional Volume
$1.4K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.89
Diluted earnings per share over the trailing twelve months.
Beta
1.33
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-16.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.85 – $5.04
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $6.4M · P/B 1.19 · P/S 0.33.

Company News

7 captured
Sonoma Pharmaceuticals shares are trading higher after the company reported a year-over-year increase in Q1 financial results.Benzinga · Aug 6, 2026, 1:03 PM
Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoYBenzinga · Aug 6, 2026, 12:34 PM
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly RevenueBenzinga · Aug 6, 2026, 12:33 PM
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance For Its Microdacyn Wound Irrigation SolutionBenzinga · Jun 30, 2026, 1:05 PM
Sonoma Pharmaceuticals Increases Maximum Aggregate Offering Price Of Common Stock To $3.64MBenzinga · Jun 18, 2026, 8:40 PM
8-K filing — Sonoma Pharmaceuticals, Inc. (SNOA)SEC EDGAR · Jun 18, 2026, 8:33 PM
Sonoma Pharmaceuticals Q4 EPS $(0.33) Misses $(0.24) Estimate, Sales $5.561M Miss $5.565M EstimateBenzinga · Jun 16, 2026, 8:20 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock